抗Human CXCR5抗体(Anti-Human CXCR5 antibody)

掲載日情報:2018/11/26 現在Webページ番号:196007

Human CXCR5に対する抗体(Anti-Human CXCR5 )です。
本製品は研究用です。研究用以外には使用できません。

価格

[在庫・価格 :2025年07月01日 18時15分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Anti-Human CXCR5 (BLR-1) MAb (Clone 51505)
10日程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 2
  • 使用文献
  • メーカーサイト
  • お問い合わせ
説明文
別名:BLR1
クローン:51505
Genbank No: 643
Protein Accession No: P32302
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 免疫動物 Mouse クラス IgG 標識 Unlabeled
交差性 Human 適用 FCM,IC,IHC,Neutralising
クロナリティ Monoclonal フォーマット 性状 Protein A/G Affinity Purified 吸収処理
掲載カタログ

製品記事
関連記事
Anti-Human CXCR5 (BLR-1) MAb (Clone 51505)
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 2
  • 使用文献
  • メーカーサイト
  • お問い合わせ
説明文
※受注発注品。形状:溶液または凍結乾燥
別名:BLR1
クローン:51505
Genbank No: 643
Protein Accession No: P32302
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 免疫動物 Mouse クラス IgG 標識 Unlabeled
交差性 Human 適用 FCM,IC,IHC,Neutralising
クロナリティ Monoclonal フォーマット 性状 Protein A/G Affinity Purified 吸収処理
掲載カタログ

製品記事 使いっきり抗体
関連記事

[在庫・価格 :2025年07月01日 18時15分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Anti-Human CXCR5 (BLR-1) MAb (Clone 51505)

文献数: 2

説明文 別名:BLR1
クローン:51505
Genbank No: 643
Protein Accession No: P32302
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 免疫動物 Mouse
交差性 Human 適用 FCM,IC,IHC,Neutralising
標識 Unlabeled 性状 Protein A/G Affinity Purified
吸収処理 クラス IgG
クロナリティ Monoclonal フォーマット
掲載カタログ

製品記事
関連記事

Anti-Human CXCR5 (BLR-1) MAb (Clone 51505)

文献数: 2

説明文 ※受注発注品。形状:溶液または凍結乾燥
別名:BLR1
クローン:51505
Genbank No: 643
Protein Accession No: P32302
別包装品 別包装品あり
法規制等
保存条件 -20℃ 法規備考
抗原種 免疫動物 Mouse
交差性 Human 適用 FCM,IC,IHC,Neutralising
標識 Unlabeled 性状 Protein A/G Affinity Purified
吸収処理 クラス IgG
クロナリティ Monoclonal フォーマット
掲載カタログ

製品記事 使いっきり抗体
関連記事



目次に戻る

Product Details

Species ReactivityHuman
LabelUnconjugated
ImmunogenNS0 mouse myeloma cell line transfected with human CXCR5Met1-Phe372Accession # P32302
SourceMonoclonal Mouse IgG2B Clone # 51505
PurificationProtein A or G purified from hybridoma culture supernatant
SpecificityStains human CXCR5 transfectants but not the parental cell lines in flow cytometry. Does not cross-react with human CXCR2, CXCR3, or CXCR4 transfectants.


目次に戻る

Applications and Data

 Recommended
Concentration
Sample
Flow Cytometry0.25 µg/106 cellsSee below
Immunohistochemistry8-25 µg/mLSee below
CyTOF-reportedFerrell, P.B., Jr. et al. (2016) PLoS ONE 11: e0153207. Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.
Immunocytochemistry8-25 µg/mLSee below
NeutralizationMeasured by its ability to neutralize CXCL13/BLC/BCA‑1-induced chemotaxis in the BaF3 mouse pro‑B cell line transfected with human CXCR5. The Neutralization Dose (ND50) is typically 0.25-1.5 µg/mL in the presence of 0.05 µg/mL Recombinant Human CXCL13/BLC/BCA‑1.


Flow Cytometry
Detection of CXCR5 in CD19+ Human PBMCs by Flow Cytometry.
Human peripheral blood mononuclear cells (PBMCs) were stained with Mouse Anti-Human CD19 APC‑conjugated Monoclonal Antibody (Catalog # FAB4867A) and either (A) Mouse Anti-Human CXCR5 Monoclonal Antibody (Catalog # MAB190) or (B) Mouse IgG2B control antibody (Catalog # MAB0041) followed by anti-Mouse IgG PE-conjugated secondary antibody (Catalog # F0102B). View our protocol for Staining Membrane-associated Proteins.
Immunocytochemistry
CXCR5 in Human PBMCs.
CXCR5 was detected in immersion fixed human peripheral blood mononuclear cells (PBMCs) using Mouse Anti-Human CXCR5 Monoclonal Antibody (Catalog # MAB190) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 637-conjugated Anti-Mouse IgG Secondary Antibody (red; Catalog # NL008) and counterstained with DAPI (blue). View our protocol for Fluorescent ICC Staining of Non-adherent Cells.
Immunohistochemistry
CXCR5 in Human Kidney.
CXCR5 was detected in immersion fixed paraffin-embedded sections of human kidney using Mouse Anti-Human CXCR5 Monoclonal Antibody (Catalog # MAB190) at 5 µg/mL overnight at 4 °C. Tissue was stained using the Anti-Mouse HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS002) and counterstained with hematoxylin (blue). Specific staining was localized to cell membranes. View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
Neutralization
Chemotaxis Induced by CXCL13/BLC/BCA‑1 and Neutralization by Human CXCR5 Antibody.
Recombinant Human CXCL13/BLC/BCA‑1 (Catalog # 801-CX) chemoattracts the BaF3 mouse pro‑B cell line transfected with human CXCR5 in a dose‑dependent manner (orange line). The amount of cells that migrated through to the lower chemotaxis chamber was measured by Resazurin (Catalog # AR002). Chemotaxis elicited by Recombinant Human CXCL13/BLC/BCA‑1 (0.05 µg/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human CXCR5 Monoclonal Antibody (Catalog # MAB190). The ND50 is typically0.25-1.5 µg/mL.


目次に戻る

Related Product & Information

Entrez Gene IDs643 (Human); 12145 (Mouse); 29363 (Rat)
BackgroundCXCR5
background_contentBackground:
CXCR5
CXCR5, also known as BLR-1, is a 7 transmembrane domain protein expressed on B cells. CXCR5 mediates B cell migration following binding of CXCL13.


目次に戻る

Citations

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
  1. p53-dependent expression of CXCR5 chemokine receptor in MCF-7 breast cancer cells.
    Authors: Mitkin N, Hook C, Schwartz A, Biswas S, Kochetkov D, Muratova A, Afanasyeva M, Kravchenko J, Bhattacharyya A, Kuprash D
    Sci Rep, 2015;5(0):9330.
    Species: Human
    Sample Type: Cell Lysates
    Application: WB

  2. Capture-stabilize approach for membrane protein SPR assays.
    Authors: Chu, Ruiyin, Reczek, David, Brondyk, William
    Sci Rep, 2014;4(0):7360.
    Species: Human
    Sample Type: Peptide
    Application: Biacore

  3. The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.
    Authors: Rasul E, Salamon D, Nagy N, Leveau B, Banati F, Szenthe K, Koroknai A, Minarovits J, Klein G, Klein E
    PLoS ONE, 2014;9(8):e106008.
    Species: Human
    Sample Type: Whole Cells
    Application: Flow

  4. CXCR7 influences the migration of B cells during maturation.
    Authors: Humpert M, Pinto D, Jarrossay D, Thelen M
    Eur J Immunol, 2014;44(3):694-705.
    Species: Human
    Sample Type: Whole Cells
    Application: Flow

  5. Blood CD4+CD45RO+CXCR5+ T cells are decreased but partially functional in signal transducer and activator of transcription 3 deficiency.
    Authors: Mazerolles F, Picard C, Kracker S, Fischer A, Durandy A
    J Allergy Clin Immunol, 2013;131(4):1146-56, 1156.
    Species: Human
    Sample Type: Whole Cells
    Application: Flow

  6. IL-15 positively regulates IL-21 production in celiac disease mucosa.
    Authors: Sarra M, Cupi M, Monteleone I, Franze E, Ronchetti G, Di Sabatino A, Gentileschi P, Franceschilli L, Sileri P, Sica G, Del Vecchio Blanco G, Cretella M, Paoluzi O, Corazza G, Pallone F, Monteleone G
    Mucosal Immunol, 2013;6(2):244-55.
    Species: Human
    Sample Type: Whole Tissue
    Application: IHC - Frozen

  7. Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells.
    Authors: Islam SA, Chang DS, Colvin RA
    Nat. Immunol., 2011;12(2):167-77.
    Species: Human
    Sample Type: Whole Cells
    Application: Flow

  8. Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion.
    Authors: Singh S, Singh R, Sharma PK, Singh UP, Rai SN, Chung LW, Cooper CR, Novakovic KR, Grizzle WE, Lillard JW
    Cancer Lett., 2009;283(1):29-35.
    Species: Human
    Sample Type: Whole Cells
    Application: Neut

  9. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.
    Authors: Cagigi A, Mowafi F, Phuong Dang LV, Tenner-Racz K, Atlas A, Grutzmeier S, Racz P, Chiodi F, Nilsson A
    Blood, 2008;112(12):4401-10.
    Species: Human
    Sample Type: Whole Tissue
    Application: IHC Paraffin-embedded

  10. Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.
    Authors: Panse J, Friedrichs K, Marx A, Hildebrandt Y, Luetkens T, Bartels K, Horn C, Stahl T, Cao Y, Milde-Langosch K, Niendorf A, Kroger N, Wenzel S, Leuwer R, Bokemeyer C, Hegewisch-Becker S, Atanackovic D
    Br. J. Cancer, 2008;99(6):930-8.
    Species: Human
    Sample Type: Tissue Homogenates
    Application: WB



目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。